{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T18:14:16Z","timestamp":1772648056756,"version":"3.50.1"},"reference-count":45,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2013,7,3]],"date-time":"2013-07-03T00:00:00Z","timestamp":1372809600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Forensic Sciences"],"published-print":{"date-parts":[[2013,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Cathinone derivatives (bath salts) have emerged as the latest drugs of abuse. 3,4\u2010methylenedioxypyrovalerone (<jats:styled-content style=\"fixed-case\">MDPV<\/jats:styled-content>) is the primary active ingredient in bath salts used in this country. This article presents the second reported cause of death by <jats:styled-content style=\"fixed-case\">MDPV<\/jats:styled-content> intoxication alone. In April 2011, a delusional man was emergently brought to a hospital, where he self\u2010reported bath salt usage. He became agitated, developed ventricular tachycardia, hyperthermia, and died. Comprehensive alcohol and drug testing was performed. Using the alkaline drug screen, heart blood contained 0.7\u00a0mg\/L <jats:styled-content style=\"fixed-case\">MDPV<\/jats:styled-content> and peripheral blood contained 1.0\u00a0mg\/L <jats:styled-content style=\"fixed-case\">MDPV<\/jats:styled-content>. His bizarre behavior with life\u2010threatening hyperthermia was consistent with an <jats:styled-content style=\"fixed-case\">MDPV<\/jats:styled-content>\u2010induced excited delirium state. <jats:styled-content style=\"fixed-case\">MDPV<\/jats:styled-content> is not yet found by routine immunoassay toxicology screens. Testing for <jats:styled-content style=\"fixed-case\">MDPV<\/jats:styled-content> should be considered in cases with a history of polysubstance abuse with stimulant type drugs, report of acute onset of psychogenic symptoms, excited delirium syndrome, or presentation in a hyperthermic state.<\/jats:p>","DOI":"10.1111\/1556-4029.12202","type":"journal-article","created":{"date-parts":[[2013,7,4]],"date-time":"2013-07-04T06:23:32Z","timestamp":1372919012000},"page":"1654-1659","source":"Crossref","is-referenced-by-count":112,"title":["Methylenedioxypyrovalerone (\u201cBath Salts\u201d),Related Death: Case Report and Review of the Literature,"],"prefix":"10.1111","volume":"58","author":[{"given":"Kilak","family":"Kesha","sequence":"first","affiliation":[{"name":"Maryland Office of the Chief Medical Examiner 900 West Baltimore Street Baltimore MD 21223"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cassie L.","family":"Boggs","sequence":"additional","affiliation":[{"name":"Maryland Office of the Chief Medical Examiner 900 West Baltimore Street Baltimore MD 21223"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary G.","family":"Ripple","sequence":"additional","affiliation":[{"name":"Maryland Office of the Chief Medical Examiner 900 West Baltimore Street Baltimore MD 21223"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carol H.","family":"Allan","sequence":"additional","affiliation":[{"name":"Maryland Office of the Chief Medical Examiner 900 West Baltimore Street Baltimore MD 21223"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barry","family":"Levine","sequence":"additional","affiliation":[{"name":"Maryland Office of the Chief Medical Examiner 900 West Baltimore Street Baltimore MD 21223"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"Jufer\u2010Phipps","sequence":"additional","affiliation":[{"name":"Maryland Office of the Chief Medical Examiner 900 West Baltimore Street Baltimore MD 21223"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzanne","family":"Doyon","sequence":"additional","affiliation":[{"name":"Maryland Poison Center 220 Arch Street Baltimore MD 21201"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"PaoLin","family":"Chi","sequence":"additional","affiliation":[{"name":"Wayne County Medical Center 1300 East Warren Detroit MI 48207"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David R.","family":"Fowler","sequence":"additional","affiliation":[{"name":"Maryland Office of the Chief Medical Examiner 900 West Baltimore Street Baltimore MD 21223"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2013,7,3]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.3109\/15563650.2011.615318"},{"key":"e_1_2_6_3_1","unstructured":"The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA).Drug profiles: synthetic cathinones.Lisbon Portugal:EMCDDA. updated September 15 2011.http:\/\/www.emcdda.europa.eu\/publications\/drug-profiles\/synthetic-cathinones(accessed January 10 2012)."},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13181-011-0193-z"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/dta.204"},{"key":"e_1_2_6_6_1","unstructured":"Hunterdon Drug Awareness Program (HDAP).Comprehensive drug information on \u201cbath salts\u201d (MDPV Mephedrone).Flemington NJ:HDAP updated December 28 2011;http:\/\/www.hdap.org\/mdpv.html(accessed January 9 2012)."},{"key":"e_1_2_6_7_1","first-page":"624","article-title":"Emergency department visits after use of a drug sold as \u201cbath salts\u201d\u2013Michigan, November 13, 2010\u2010March 31, 2011","volume":"19","author":"Benzie F","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"e_1_2_6_8_1","unstructured":"Drug Enforcement Administration\/Office of Diversion Control\/Drug & Chemical Evaluation Section.3 4\u2010Methylenedioxypyrovalerone (MDPV);http:\/\/www.DEAdiversion.usdoj.gov\/drugs_concern\/mdpv.pdf(accessed July 20 2011 and January 10 2012)."},{"key":"e_1_2_6_9_1","unstructured":"WehrmanJ.U.S. Poison Centers raise alarm about toxic substance marketed as bath salts [press release].Alexandria VA:American Association of Poison Control Centers (AAPCC) December 21 2010."},{"key":"e_1_2_6_10_1","unstructured":"American Association of Poison Control Centers (AAPCC).Bath salts data.Alexandria VA:AAPCC updated January 5 2012;http:\/\/www.aapcc.org\/dnn\/Portals\/0\/Bath%20Salts%20Data%20for%20Website%201.5.2012.pdf (accessed January 9 2012)."},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.3109\/15563650.2011.635149"},{"key":"e_1_2_6_12_1","volume-title":"Consideration of the cathinones","author":"Iversen L","year":"2010"},{"key":"e_1_2_6_13_1","unstructured":"National Conference of State Legislation (NCSL).Substituted cathinones legislation.Washington DC:NCSL updated October 24 2011;http:\/\/www.ncsl.org\/?TabId=22432(accessed January 10 2012)."},{"key":"e_1_2_6_14_1","unstructured":"North Yorkshire Police. MDPV.Northallerton England: North Yorkshire Police February2011;http:\/\/www.northyorkshire.police.uk\/mdpv(accessed January 10 2012)."},{"issue":"1","key":"e_1_2_6_15_1","first-page":"12","article-title":"The characterization of 3,4\u2010Methylenedioxypyrovalerone (MDPV). US\u2010DOJ\u201043 Special Testing Research Laboratory","volume":"7","author":"Yohannan JC","year":"2010","journal-title":"Microgram J"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.3109\/15563650.2011.590812"},{"issue":"6","key":"e_1_2_6_17_1","first-page":"640.e5\u20106","article-title":"Paranoid psychosis induced by consumption of methylenedioxypyrovalerone: two cases","volume":"33","author":"Antonowicz JL","year":"2011","journal-title":"Gen Hosp Psychiatry"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.forsciint.2011.03.015"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.toxlet.2011.10.002"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.3109\/00952990.2011.643999"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1093\/anatox\/35.3.188"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1136\/emj.2010.103093"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.3109\/15563650.2010.531021"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1136\/emj.2010.096636"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1002\/rcm.4692"},{"issue":"2","key":"e_1_2_6_26_1","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/FTD.0b013e318208b693","article-title":"Urine analysis of 3,4\u2010methylenedioxypyrovalerone in opioid\u2010dependent patients by gas chromatography\u2010mass spectrometry","volume":"33","author":"Ojanper\u00e4 IA","year":"2011","journal-title":"Ther Drug Monit"},{"issue":"20","key":"e_1_2_6_27_1","first-page":"237","article-title":"Legal drugs of abuse","volume":"32","author":"Quan D","year":"2011","journal-title":"Emerg Med Reports"},{"key":"e_1_2_6_28_1","unstructured":"Expert Committee on Drug Dependence (ECDD).Assessment of khat (Catha edulis Forsk).Geneva Switzerland:World Health Organization 2006March 28\u201331. Report No.: 34th ECDD 2006\/4.4;1\u201325;http:\/\/www.who.int\/medicines\/areas\/quality_safety\/4.4KhatCritReview.pdf(accessed January 10 2012)."},{"issue":"10","key":"e_1_2_6_29_1","first-page":"631","article-title":"Evaluation of pyrovalerone in chronically fatigued volunteers","volume":"13","author":"Gardos G","year":"1971","journal-title":"Curr Ther Res Clin Exp"},{"issue":"1","key":"e_1_2_6_30_1","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1159\/000467975","article-title":"A controlled evaluation of pyrovalerone in chronically fatigued volunteers","volume":"8","author":"Goldberg J","year":"1973","journal-title":"Int Pharmacopsychiatry"},{"key":"e_1_2_6_31_1","first-page":"287","article-title":"Microdialysis study of drugs on the central nervous system. Changes of dopamine levels in mice striatum after oral administration of methylenedioxypyrovalerone","volume":"58","author":"Fuwa T","year":"2007","journal-title":"Tokyo\u2010to Kenko Anzen Kenkyu Senta Kenkyu Nenpo"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm050797a"},{"key":"e_1_2_6_33_1","first-page":"62","article-title":"Influence of methylenedioxypyrovalerone on central nervous system using microdialysis method","volume":"5","author":"Fuwa T","year":"2009","journal-title":"Chem Bio Integrated Management"},{"key":"e_1_2_6_34_1","unstructured":"The vaults of Erowid;http:\/\/www.erowid.org\/chemicals\/mdpv\/(accessed January 12 2012)."},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.genhosppsych.2011.05.014"},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1107097"},{"issue":"6","key":"e_1_2_6_37_1","first-page":"523","article-title":"Case series of bath salts exposures with blood and urine quantification","volume":"49","author":"Spiller HA","year":"2011","journal-title":"Clin Toxicol"},{"key":"e_1_2_6_38_1","unstructured":"Michigan Poison Control.\u201cBath salts\u201d health care provider fact sheet. Published February 2011 updated Sept 2011;http:\/\/www.michigan.gov\/documents\/mdch\/Bath_Salts_FAQ_Health_Care_Providers_344881_7pdf (accessed July 7 2011)."},{"key":"e_1_2_6_39_1","doi-asserted-by":"publisher","DOI":"10.1136\/emj.2011.112920"},{"key":"e_1_2_6_40_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2011.10.012"},{"issue":"1","key":"e_1_2_6_41_1","doi-asserted-by":"crossref","first-page":"e124","DOI":"10.3928\/01477447-20111122-36","article-title":"Life\u2010threatening necrotizing fasciitis due to \u2018bath salts\u2019 injection","volume":"35","author":"Russo R","year":"2012","journal-title":"Orthopedics"},{"key":"e_1_2_6_42_1","doi-asserted-by":"publisher","DOI":"10.1002\/dta.155"},{"key":"e_1_2_6_43_1","unstructured":"3 4\u2010Methylenedioxypyrovalerone (MDPV) [press release]. Drug Enforcement Administration\/Office of Diversion Control\/Drug & Chemical Evaluation Section. October 21 2011."},{"issue":"204","key":"e_1_2_6_44_1","first-page":"65371","article-title":"Schedules of controlled substances: temporary placement of three synthetic cathinones in Schedule 1. Final Order","volume":"76","author":"Drug Enforcement Administration, Department of Justice","year":"2011","journal-title":"Fed Regist"},{"key":"e_1_2_6_45_1","doi-asserted-by":"publisher","DOI":"10.1002\/dta.306"},{"key":"e_1_2_6_46_1","doi-asserted-by":"publisher","DOI":"10.1002\/jms.1859"}],"container-title":["Journal of Forensic Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2F1556-4029.12202","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/1556-4029.12202","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T14:29:12Z","timestamp":1696256952000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/1556-4029.12202"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7,3]]},"references-count":45,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["10.1111\/1556-4029.12202"],"URL":"https:\/\/doi.org\/10.1111\/1556-4029.12202","archive":["Portico"],"relation":{},"ISSN":["0022-1198","1556-4029"],"issn-type":[{"value":"0022-1198","type":"print"},{"value":"1556-4029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7,3]]}}}